OBJECTIVES: We ascertained a large kindred with an excess of Lynch syndrome-associated cancers. Our objective was to determine if a defect in one of the DNA mismatch repair (DMMR) genes was the probable cause of cancer susceptibility as microsatellite instability (MSI) and immunohistochemical (IHC) analysis of the probands' tumors did not provide a clear indication. METHODS: A detailed history and review of medical records was undertaken to construct a four-generation pedigree. Blood samples were obtained for analysis of germline DNA. Polymorphic repeats from the MLH1, MSH2, MSH6, and PMS2 loci were genotyped and the co-segregation of markers and disease was assessed. DMMR gene expression for all available tumors was evaluated by IHC. Combined bisulfite restriction analysis (COBRA) of MLH1 was utilized to test for germline epimutation. RESULTS: Four gynecologic carcinomas, 3 colon carcinomas, and 13 cases of adenomatous polyps were identified. The family met Amsterdam II criteria. The mean age of cancer diagnosis in the kindred was 63 years (range 44-82 years). DNA marker analyses excluded linkage to MLH1, MSH2, MSH6, and PMS2. Furthermore, MSI and IHC analysis of tumors did not suggest a role for DMMR. Methylation of the MLH1 promoter was identified in the peripheral blood leukocytes (PBLs) of a family member with an early onset colon cancer. CONCLUSIONS: We identified a large family with multiple Lynch malignancies and no evidence for an inherited defect in DMMR. This family represents an important but poorly understood form of autosomal dominant inherited cancer susceptibility. Aberrant MLH1 promoter methylation in normal tissues may be a marker for cancer susceptibility in families such as this.
OBJECTIVES: We ascertained a large kindred with an excess of Lynch syndrome-associated cancers. Our objective was to determine if a defect in one of the DNA mismatch repair (DMMR) genes was the probable cause of cancer susceptibility as microsatellite instability (MSI) and immunohistochemical (IHC) analysis of the probands' tumors did not provide a clear indication. METHODS: A detailed history and review of medical records was undertaken to construct a four-generation pedigree. Blood samples were obtained for analysis of germline DNA. Polymorphic repeats from the MLH1, MSH2, MSH6, and PMS2 loci were genotyped and the co-segregation of markers and disease was assessed. DMMR gene expression for all available tumors was evaluated by IHC. Combined bisulfite restriction analysis (COBRA) of MLH1 was utilized to test for germline epimutation. RESULTS: Four gynecologic carcinomas, 3 colon carcinomas, and 13 cases of adenomatous polyps were identified. The family met Amsterdam II criteria. The mean age of cancer diagnosis in the kindred was 63 years (range 44-82 years). DNA marker analyses excluded linkage to MLH1, MSH2, MSH6, and PMS2. Furthermore, MSI and IHC analysis of tumors did not suggest a role for DMMR. Methylation of the MLH1 promoter was identified in the peripheral blood leukocytes (PBLs) of a family member with an early onset colon cancer. CONCLUSIONS: We identified a large family with multiple Lynch malignancies and no evidence for an inherited defect in DMMR. This family represents an important but poorly understood form of autosomal dominant inherited cancer susceptibility. Aberrant MLH1 promoter methylation in normal tissues may be a marker for cancer susceptibility in families such as this.
Authors: Laura Valle; Jose Perea; Pablo Carbonell; Victoria Fernandez; Ana M Dotor; Javier Benitez; Miguel Urioste Journal: J Clin Oncol Date: 2007-01-16 Impact factor: 44.544
Authors: M A Rodriguez-Bigas; C R Boland; S R Hamilton; D E Henson; J R Jass; P M Khan; H Lynch; M Perucho; T Smyrk; L Sobin; S Srivastava Journal: J Natl Cancer Inst Date: 1997-12-03 Impact factor: 13.506
Authors: S N Thibodeau; A J French; J M Cunningham; D Tester; L J Burgart; P C Roche; S K McDonnell; D J Schaid; C W Vockley; V V Michels; G H Farr; M J O'Connell Journal: Cancer Res Date: 1998-04-15 Impact factor: 12.701
Authors: S B Simpkins; T Bocker; E M Swisher; D G Mutch; D J Gersell; A J Kovatich; J P Palazzo; R Fishel; P J Goodfellow Journal: Hum Mol Genet Date: 1999-04 Impact factor: 6.150
Authors: M G Dunlop; S M Farrington; A D Carothers; A H Wyllie; L Sharp; J Burn; B Liu; K W Kinzler; B Vogelstein Journal: Hum Mol Genet Date: 1997-01 Impact factor: 6.150
Authors: J R Jass; D S Cottier; P Jeevaratnam; V Pokos; K M Holdaway; M L Bowden; N S Van de Water; P J Browett Journal: Lancet Date: 1995-11-04 Impact factor: 79.321
Authors: David W Brammer; Patrick J Gillespie; Mei Tian; Daniel Young; Muthuswamy Raveendran; Lawrence E Williams; Mihai Gagea; Fernando J Benavides; Carlos J Perez; Russell R Broaddus; Bruce J Bernacky; Kirstin F Barnhart; Mian M Alauddin; Manoop S Bhutani; Richard A Gibbs; Richard L Sidman; Renata Pasqualini; Wadih Arap; Jeffrey Rogers; Christian R Abee; Juri G Gelovani Journal: Proc Natl Acad Sci U S A Date: 2018-02-28 Impact factor: 11.205
Authors: Katherine E Varley; David G Mutch; Tina B Edmonston; Paul J Goodfellow; Robi D Mitra Journal: Nucleic Acids Res Date: 2009-06-03 Impact factor: 16.971